Home / Without Label / CTMX CytomX Therapeutics, Inc. gains 16% Mar 20, 2018

Tuesday, March 20, 2018

CTMX CytomX Therapeutics, Inc. gains 16% Mar 20, 2018

priceSeries Tuesday, March 20, 2018 0 Comment

Preclinical biotech developing tumor-activated cancer immunotherapies. http://www.priceseries.com/trade/CTMX-CytomX-Therapeutics-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018022120180320.html

Posted by : priceSeries Tuesday, March 20, 2018

No Comments

Subscribe to: Post Comments (Atom)